Patents by Inventor Maja Matanovic Skugor

Maja Matanovic Skugor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124393
    Abstract: Disclosed is a process for the preparation of Omaveloxolone and salts thereof, as well as intermediates thereof.
    Type: Application
    Filed: September 21, 2023
    Publication date: April 18, 2024
    Inventors: Tomislav Biljan, Ivana Sagud, Dubravka Pavlicic, Maja Matanovic Skugor
  • Patent number: 11512096
    Abstract: The present invention relates to seco (opened ring) macrolide compounds, to the process for preparation thereof, to the use of said seco macrolide compounds as intermediates for preparation of macrolide based macrocycles, to macrolide based macrocycles obtained from said seco macrolide compounds, to the process for preparation of macrolide based macrocycles, to the pharmaceutical compositions comprising macrolide based macrocycles, and to the use of macrolide based macrocycles as therapeutic agents.
    Type: Grant
    Filed: December 24, 2020
    Date of Patent: November 29, 2022
    Assignee: SELVITA D.O.O.
    Inventors: Andrea Fajdetic, Maja Matanovic Skugor, Ivaylo Jivkov Elenkov, Goran Kragol, Mirjana Bukvic, Zorica Marusic Istuk, Sanja Kostrun, Dinko Ziher, Renata Rupcic, Kristina Butkovic, Marko Duksi, Ivana Ozimec Landek, Dijana Pesic, Antun Hutinec, Milan Mesic, Gordon Saxty, Visnja Poljak
  • Publication number: 20210198278
    Abstract: The present invention relates to seco (opened ring) macrolide compounds, to the process for preparation thereof, to the use of said seco macrolide compounds as intermediates for preparation of macrolide based macrocycles, to macrolide based macrocycles obtained from said seco macrolide compounds, to the process for preparation of macrolide based macrocycles, to the pharmaceutical compositions comprising macrolide based macrocycles, and to the use of macrolide based macrocycles as therapeutic agents.
    Type: Application
    Filed: December 24, 2020
    Publication date: July 1, 2021
    Inventors: Andrea FAJDETIC, Maja MATANOVIC SKUGOR, Ivaylo Jivkov ELENKOV, Goran KRAGOL, Mirjana BUKVIC, Zorica MARUSIC ISTUK, Sanja KOSTRUN, Dinko ZIHER, Renata RUPCIC, Kristina BUTKOVIC, Marko DUKSI, Ivana OZIMEC LANDEK, Dijana PESIC, Antun HUTINEC, Milan MESIC, Gordon SAXTY, Visnja POLJAK
  • Publication number: 20210163498
    Abstract: The present disclosure relates to Lorlatinib solid state forms, Lorlatinib salts and solid states thereof, processes for preparation thereof, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: April 19, 2019
    Publication date: June 3, 2021
    Inventors: Maja Matanovic Skugor, Ivica Grebenar, Nea Baus Topic, Dijana Skalec Samec, Edi Topic
  • Patent number: 10919910
    Abstract: The present invention relates to seco (opened ring) macrolide compounds, to the process for preparation thereof, to the use of said seco macrolide compounds as intermediates for preparation of macrolide based macrocycles, to macrolide based macrocycles obtained from said seco macrolide compounds, to the process for preparation of macrolide based macrocycles, to the pharmaceutical compositions comprising macrolide based macrocycles, and to the use of macrolide based macrocycles as therapeutic agents.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: February 16, 2021
    Assignee: FIDELTA D.O.O.
    Inventors: Andrea Fajdetic, Maja Matanovic Skugor, Ivaylo Jivkov Elenkov, Goran Kragol, Mirjana Bukvic, Zorica Marusic Istuk, Sanja Kostrun, Dinko Ziher, Renata Rupcic, Kristina Butkovic, Marko Duksi, Ivana Ozimec Landek, Dijana Pesic, Antun Hutinec, Milan Mesic, Gordon Saxty, Visnja Poljak
  • Patent number: 10875870
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: December 29, 2020
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Patent number: 10807953
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: October 20, 2020
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20200017522
    Abstract: The present invention relates to seco (opened ring) macrolide compounds, to the process for preparation thereof, to the use of said seco macrolide compounds as intermediates for preparation of macrolide based macrocycles, to macrolide based macrocycles obtained from said seco macrolide compounds, to the process for preparation of macrolide based macrocycles, to the pharmaceutical compositions comprising macrolide based macrocycles, and to the use of macrolide based macrocycles as therapeutic agents.
    Type: Application
    Filed: May 8, 2017
    Publication date: January 16, 2020
    Inventors: Andrea FAJDETIC, Maja MATANOVIC SKUGOR, Ivaylo Jivkov ELENKOV, Goran KRAGOL, Mirjana BUKVIC, Zorica MARUSIC ISTUK, Sanja KOSTRUN, Dinko ZIHER, Renata RUPCIC, Kristina BUTKOVIC, Marko DUKSI, Ivana OZIMEC LANDEK, Dijana PESIC, Antun HUTINEC, Milan MESIC, Gordon SAXTY, Visnja POLJAK
  • Publication number: 20190389871
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 23, 2018
    Publication date: December 26, 2019
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Publication number: 20190276401
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Patent number: 10343993
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: July 9, 2019
    Assignee: Pliva Hrvatska d.o.o.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20180037549
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: March 2, 2016
    Publication date: February 8, 2018
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Publication number: 20110281812
    Abstract: 2?-O-substituted 14- or 15-membered azalide macrolides of Formula (I) wherein R6 represents (i) —C1-8alkyl, unsubstituted or substituted at the terminal carbon atom by a group selected from hydroxy, —C1-3alkoxy and —C(O)OC1-3alkyl, or when —C1-8alkyl is branched, substitution can alternatively be by a hydroxyl group at each of two terminal carbon atoms, (ii) —CH(NH2)C1-4alkyl, wherein the —C1-4alkyl group may be optionally interrupted by a heteroatom selected from O, S and N, (iii) —CH2N(R7)(R8), wherein R7 and R8 each independently represent H or —C1-3alkyl provided that R7 and R8 cannot both simultaneously represent H, (iv) a 4-6-membered heterocyclic ring containing up to 2 heteroatoms independently selected from O, S and N, wherein the heterocyclic ring is unsubstituted or substituted by —C1-3alkyl, (v) 5-6 membered heteroaromatic ring, unsubstituted or substituted by one to three groups independently selected from halo, hydroxyl, —C1-3alkyl, —C1-3alkoxy, —CF3, —OCF3 and —NH2, (vi) —CH(NH2)CH
    Type: Application
    Filed: January 28, 2010
    Publication date: November 17, 2011
    Inventors: Sulejman Alihodzic, Antun Hutinec, Sanja Kostrun, Maja Matanovic Skugor, Ivana Palej Jakopovic
  • Publication number: 20080255060
    Abstract: The present invention relates to 14- or 15-membered macrolides substituted at the 4? position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
    Type: Application
    Filed: May 2, 2005
    Publication date: October 16, 2008
    Inventors: Sulejman Alihodzic, Stjepan Mutak, Drazen Pavlovic, Ivana Palej, Vlado Stimac, Samra Kapic, Adrijana Vinter, Maja Matanovic Skugor